Timeline
Last
$132.76
-34.06 (-20.42%)
24HR-20.4%
1W-22.2%
1M-16.9%
1Y-52.8%
Valuation
- Market Cap
- $9.2B
- Enterprise Value
- $12.3B
- P/E (TTM)
- 31.02x
- Forward P/E
- 16.48x
- Price / Sales
- 3.17x
- EV / EBITDA
- 20.41x
Cash Flow
- Operating Cash Flow
- $619.3M
- Free Cash Flow
- $253.4M
- FCF Margin
- 8.7%
- Cash Conversion
- 40.9%
- Cash / Share
- $6.9
Margins & Growth
- Gross Margin
- 71.0%
- Operating Margin
- 16.0%
- EBITDA Margin
- 20.8%
- Net Margin
- 10.4%
- Revenue Growth
- 33.9%
- Earnings Growth
- 159.0%
Balance Sheet
- Total Cash
- $480.4M
- Total Debt
- $1B
- Net Cash
- -$533.6M
- Debt / Equity
- 0.78x
- Current Ratio
- 2.49x
- Quick Ratio
- 1.49x
Returns & Ownership
- Return on Assets
- 9.7%
- Return on Equity
- 23.0%
- Dividend Yield
- —
- Payout Ratio
- 0.0%
- Beta
- 1.09
- Institutional Ownership
- 105.4%
Latest EPS$1.66+0.1% surprise
Beat rate100%4 print streak
Avg surprise+0.1%vs consensus
Next printAug 5, 2026EPS $1.64
Quarterly EPS vs consensus
4 quarters Actual ConsensusLabels: beat $ · YoY %Revisions 1 up / 17 down
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QSep 2026
$1.64$845.5M+32.1%+1QDec 2026
$1.97$928.7M+26.8%0YDec 2026
$6.48$3.3B+30.4%+1YDec 2027
$8.05$3.9B+24.3%Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
8-KCorporate Changes & Voting Matters2026-08-058-KCorporate Changes & Voting Matters2026-06-258-KCorporate Changes & Voting Matters2026-05-268-KCorporate Changes & Voting Matters2026-05-2110-QPeriodic Financial Reports2026-05-068-KCorporate Changes & Voting Matters2026-04-298-KCorporate Changes & Voting Matters2026-03-128-KCorporate Changes & Voting Matters2026-03-0410-KPeriodic Financial Reports2026-02-188-KCorporate Changes & Voting Matters2026-02-038-KCorporate Changes & Voting Matters2025-12-198-KCorporate Changes & Voting Matters2025-12-17
PODD stock research · Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values th…
| Last price | $132.8 |
|---|---|
| Day change | -34.06 (-20.42%) |
| Market cap | $9.2B |
| P/E (TTM) | 31.02x |
| Sector | Healthcare |
| Industry | Medical Devices |